InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Xenon Pharmaceuticals Inc.

XENE Clue Score32
British Columbia, Canada Fiscal year ends December CIK 0001582313 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

30
Insider
Date
Role
Action
Shares
Price
Amount
Ian Mortimer
30 Sep 2026
President & CEO
Buy
30,000
$37.38
$1.12M
Thomas Patrick Kelly
30 Sep 2026
Chief Financial Officer
Buy
15,000
$37.32
$559.74K
Dawn Svoronos
1 Sep 2026
Director
Exercised, kept
5,144
$8.15
$41.92K
Christopher John Kenney
28 Aug 2026
Chief Medical Officer
Sold on a plan
700
$60.98
$42.68K
Christopher John Kenney
28 Aug 2026
Chief Medical Officer
Sold on a plan
6,368
$60.17
$383.15K
Steven Gannon
11 Aug 2026
Director
Sell
10,000
$64.06
$640.55K
Gillian Cannon
5 Jun 2026
Director
Sold on a plan
1,190
$53.14
$63.24K
Gary Patou
5 Jun 2026
Director
Sold on a plan
1,322
$53.14
$70.25K
Steven Gannon
12 May 2026
Director
Exercised, kept
3,500
$7.38
$25.83K
Ian Mortimer
13 Mar 2026
President & CEO
Sold on a plan
7,308
$55.23
$403.58K
Andrea DiFabio
13 Mar 2026
Chief Legal Officer
Sold on a plan
1,342
$55.23
$74.11K
Christopher John Kenney
13 Mar 2026
Chief Medical Officer
Sold on a plan
1,410
$55.23
$77.87K
Ian Mortimer
10 Mar 2026
President & CEO
Sold on a plan
11,269
$60.11
$677.36K
Andrea DiFabio
10 Mar 2026
Chief Legal Officer
Sold on a plan
2,607
$60.11
$156.70K
Christopher John Kenney
10 Mar 2026
Chief Medical Officer
Sold on a plan
2,771
$60.11
$166.56K
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
65,000
$62.06
$4.03M
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
61,652
$60.08
$3.70M
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
43,348
$59.26
$2.57M
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
2,449
$61.26
$150.03K
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
10,072
$60.47
$609.05K
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
12,479
$59.50
$742.50K
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
21,515
$60.49
$1.30M
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
31,694
$59.88
$1.90M
Ian Mortimer
9 Mar 2026
President & CEO
Sold after exercise
21,791
$58.81
$1.28M
Ian Mortimer
2 Jan 2026
President & CEO
Sold after exercise
2,062
$44.93
$92.65K
Ian Mortimer
2 Jan 2026
President & CEO
Sold after exercise
37,938
$44.40
$1.68M
Ian Mortimer
8 Dec 2025
President & CEO
Sold on a plan
2,010
$46.32
$93.10K
Ian Mortimer
8 Dec 2025
President & CEO
Sold on a plan
8,820
$45.59
$402.10K
Ian Mortimer
5 Dec 2025
President & CEO
Sold on a plan
14,375
$45.03
$647.31K
Ian Mortimer
28 Nov 2025
President & CEO
Sold on a plan
97
$45.01
$4.37K

What was left out

Form 4 filings counted 29
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 11
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 402,491
History held since 6 Nov 2014